Acute lymphoblastic leukemia in a girl treated for osteosarcoma.
Acute lymphoblastic leukemia (ALL) was diagnosed in a 13-year-old girl who had been treated previously for osteosarcoma of the left distal femur (23 months after her first cancer onset and 12 months after the end of treatment). The patient started chemotherapy for ALL and achieved complete remission; she is in continuous complete remission 5 years after the diagnosis of secondary ALL and 7 years after the onset of osteosarcoma.
Miniero
R
R
Department of Pediatrics, University of Turin, Italy.
Barisone
E
E
Vivenza
C
C
Brach del Prever
A
A
Besenzon
L
L
Cordero di Montezemolo
L
L
Madon
E
E
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D001215:Asparaginase / Q000008:administration & dosage; D002648:Child; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D003630:Daunorubicin / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D005266:Femoral Neoplasms / Q000628:therapy*; D005500:Follow-Up Studies; D006801:Humans; D015122:Mercaptopurine / Q000008:administration & dosage; D008727:Methotrexate / Q000008:administration & dosage; D016609:Neoplasms, Second Primary / Q000139:chemically induced*; D012516:Osteosarcoma / Q000150:complications* / Q000628:therapy; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000209:etiology* / Q000628:therapy; D011241:Prednisone / Q000008:administration & dosage; D011829:Radiation Dosage; D018714:Radiotherapy, Adjuvant; D012074:Remission Induction; D014750:Vincristine / Q000008:administration & dosage
D014750:Vincristine; D004317:Doxorubicin; D015122:Mercaptopurine; D001215:Asparaginase; D002945:Cisplatin; D011241:Prednisone; D008727:Methotrexate; D003630:Daunorubicin